[
  {
    "ts": null,
    "headline": "Cigna: Looks More Interesting Here Than UnitedHealth Group",
    "summary": "Cigna's stock offers potential 35% upside with strong earnings & attractive valuation.",
    "url": "https://finnhub.io/api/news?id=faaa49bde0cd25e443422c5e851fd5c1e224038de87e508d1f7a3e37a7d2471c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754483379,
      "headline": "Cigna: Looks More Interesting Here Than UnitedHealth Group",
      "id": 136238580,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1882294059/image_1882294059.jpg?io=getty-c-w1536",
      "related": "CI",
      "source": "SeekingAlpha",
      "summary": "Cigna's stock offers potential 35% upside with strong earnings & attractive valuation.",
      "url": "https://finnhub.io/api/news?id=faaa49bde0cd25e443422c5e851fd5c1e224038de87e508d1f7a3e37a7d2471c"
    }
  },
  {
    "ts": null,
    "headline": "The great Medicare Advantage contraction appears set to continue",
    "summary": "Insurers plan to keep sacrificing MA growth for profitability next year, after second quarter results for Humana and CVS showed the success of the strategy.",
    "url": "https://finnhub.io/api/news?id=daf3e8990696ba938d72e19189c5e06ac3e761c57685de1001ac7e2b690ab243",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754476977,
      "headline": "The great Medicare Advantage contraction appears set to continue",
      "id": 136239038,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "Insurers plan to keep sacrificing MA growth for profitability next year, after second quarter results for Humana and CVS showed the success of the strategy.",
      "url": "https://finnhub.io/api/news?id=daf3e8990696ba938d72e19189c5e06ac3e761c57685de1001ac7e2b690ab243"
    }
  },
  {
    "ts": null,
    "headline": "Oscar Health Announces Financial Results for Second Quarter 2025 and Reaffirms Updated 2025 Guidance",
    "summary": "NEW YORK, August 06, 2025--Oscar Health, Inc. (\"Oscar\" or the \"Company\") (NYSE: OSCR) announced today its financial results for the second quarter ended June 30, 2025, and reaffirmed its updated full year 2025 outlook across all metrics as provided in its preliminary financial results press release dated July 22, 2025.",
    "url": "https://finnhub.io/api/news?id=028ec51daca5e14508de47cb328b73fd986b60da9646754e90454d1962038944",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754474400,
      "headline": "Oscar Health Announces Financial Results for Second Quarter 2025 and Reaffirms Updated 2025 Guidance",
      "id": 136232457,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "NEW YORK, August 06, 2025--Oscar Health, Inc. (\"Oscar\" or the \"Company\") (NYSE: OSCR) announced today its financial results for the second quarter ended June 30, 2025, and reaffirmed its updated full year 2025 outlook across all metrics as provided in its preliminary financial results press release dated July 22, 2025.",
      "url": "https://finnhub.io/api/news?id=028ec51daca5e14508de47cb328b73fd986b60da9646754e90454d1962038944"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare Stocks Have Been Beaten Up. The Case for Buying Now.",
    "summary": "Healthcare stocks have been the sick man of the  this year.  The  exchange-traded fund has fallen 3.7% this year, far worse than the S&P 500’s 7.1% rise.  The ETF includes everything from insurers to pharma companies to medical-device makers, and that diversity usually helps the group weather the tough times.",
    "url": "https://finnhub.io/api/news?id=9a8e4064a99bde35e95e225106c6771e3156aa6b8dc50846fccc1e9bb0a4e06f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754469000,
      "headline": "Healthcare Stocks Have Been Beaten Up. The Case for Buying Now.",
      "id": 136232196,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "Healthcare stocks have been the sick man of the  this year.  The  exchange-traded fund has fallen 3.7% this year, far worse than the S&P 500’s 7.1% rise.  The ETF includes everything from insurers to pharma companies to medical-device makers, and that diversity usually helps the group weather the tough times.",
      "url": "https://finnhub.io/api/news?id=9a8e4064a99bde35e95e225106c6771e3156aa6b8dc50846fccc1e9bb0a4e06f"
    }
  },
  {
    "ts": null,
    "headline": "Auxier Asset Management Summer 2025 Market Commentary",
    "summary": "Markets have been a rollercoaster for investors in 2025, with every major benchmark starting the year down in the first quarter to all being up for the second quarter and year-to-date.",
    "url": "https://finnhub.io/api/news?id=eadda7b84c914659d8a4bacbbdaaa3f292348896b4f845a356bbe7409ff8c4a3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754455140,
      "headline": "Auxier Asset Management Summer 2025 Market Commentary",
      "id": 136231483,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2215724553/image_2215724553.jpg?io=getty-c-w1536",
      "related": "CI",
      "source": "SeekingAlpha",
      "summary": "Markets have been a rollercoaster for investors in 2025, with every major benchmark starting the year down in the first quarter to all being up for the second quarter and year-to-date.",
      "url": "https://finnhub.io/api/news?id=eadda7b84c914659d8a4bacbbdaaa3f292348896b4f845a356bbe7409ff8c4a3"
    }
  }
]